Mov Disord Vol 31, Suppl 2 Archives - Page 26 of 207 - MDS Abstracts

2016 International Congress
Histology of subcutaneous nodules in PD patients treated with continuous apomorphine infusion: Case series and review of the literature
R.W.K. Borgemeester, G.F.H. Diercks, M.L.A. Schuttelaar, T. van Laar (Groningen, Netherlands)
Objective: To examine the histology of subcutaneous nodules after continuous subcutaneous apomorphine infusion (CSAI). Background: CSAI has been used successfully in advanced Parkinson's disease (PD).…
2016 International Congress
Healthcare burden of Parkinson’s disease
M. Tagliati, A.T. Connolly (Los Angeles, CA, USA)
Objective: Evaluate healthcare costs for a cross-section of patients with Parkinson's disease (PD). Background: PD is a progressive, nonfatal condition with an increasing societal cost…
2016 International Congress
Pallidal versus subthalamic stimulation for PD: Beyond the motor effects
M.G. dos Santos Ghilardi, R.G. Cury, R.C.R. Martinez, M.J. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)
Objective: To evaluate the effects of Deep Brain Stimulation(DBS) on non motor symptoms(NMS) in Parkinson's disease(PD) and compare the efficacy of pallidal(GPi) versus subthalamic(STN) stimulation.…
2016 International Congress
Blindfolded balance training in patients with Parkinson’s disease: A sensory-motor strategy to improve the gait
A. Peppe, S. Bonnì, M. Fabio, K. Giacomo, A. Martino Cinnera, M. Tramontano, C. Caltagirone (Rome, Italy)
Objective: Recent evidence suggested that the use of treadmill training may improve gait parameters, such as gait speed and stride length. Visual deprivation could engage…
2016 International Congress
Medication use patterns vary across expert Parkinson’s disease clinics
P. Schmidt, F. Cubillos, T. Simuni, C. Marras, T. Davis, E.C. Nelson (Miami, FL, USA)
Objective: This analysis aims to describe and quantify the medication patterns for patients with Parkinson's disease (PD) managed in expert clinics. Background: Antiparkinson medication use…
2016 International Congress
Clinical benefits of vestibular rehabilitation in neurodegenerative diseases
B.S. Zeigelboim, G.B. Santos, H.A.G. Teive, M.I.R. Severiano, C.M. Porto (Curitiba, Brazil)
Objective: To assess the benefits of vestibular rehabilitation using virtual reality technology through pre and post application of the Dizziness Handicap Inventory (DHI) and the…
2016 International Congress
Effect of outside influences on the therapeutic benefits of botulinum toxin injections
D.C. Taylor, P.A. LeWItt, P. Kaminski (Royal Oak, MI, USA)
Objective: The purpose of this project is to determine if outside influences or stressors have an effect on the therapeutic benefit of botulinum toxin injections…
2016 International Congress
Systematic literature review of quetiapine for hallucinosis / psychosis in Parkinson’s disease (PD)
K. Dashtipour, J.J. Chen, L. Massihi, S. Tashiro, K. Frei (Loma Linda, CA, USA)
Objective: To conduct a systematic review to evaluate the efficacy, safety, and dosing range of quetiapine for the treatment for hallucinosis / psychosis in patients…
2016 International Congress
DBS targeting: Validation of 3T MR image guided targeting using post-mortem 17T MR microscopy
J.D. Hilliard, T. Morishita, C.H. Lee, S.J. Blackband, M.S. Okun, K.D. Foote (Gainesville, FL, USA)
Objective: This work helps validate the utility of direct targeting using 3T T1 inverted sequences with atlas application during planning for DBS electrode placement. We…
2016 International Congress
The core assessment program for surgical interventional therapies in Parkinson’s disease (CAPSIT-PD): Tolerability of preoperative neuropsychological testing for deep brain stimulation in Parkinson’s disease
G.D. Pal, V. Persinger, B. Bernard, B. Ouyang, C. Goetz, L. Verhagen (Chicago, IL, USA)
Objective: We examined tolerability of preoperative neuropsychological testing (the Core Assessment Program for Surgical Interventional Therapies in Parkinson's disease [CAPSIT-PD] protocol) for DBS. Background: CAPSIT-PD…